Development and validation of a surgical prioritization and ranking tool and navigation aid for head and neck cancer (SPARTAN-HN) in a scarce resource setting: Response to the COVID-19 pandemic
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Background : In the wake of the coronavirus disease 2019 (COVID?19) pandemic, access to surgical care for patients with head and neck cancer (HNC) is limited and unpredictable. Determining which patients should be prioritized is inherently subjective and difficult to assess. The authors have proposed an algorithm to fairly and consistently triage patients and mitigate the risk of adverse outcomes. Methods : Two separate expert panels, a consensus panel (11 participants) and a validation panel (15 participants), were constructed among international HNC surgeons. Using a modified Delphi process and RAND Corporation/University of California at Los Angeles methodology with 4 consensus rounds and 2 meetings, groupings of high?priority, intermediate?priority, and low?priority indications for surgery were established and subdivided. A point?based scoring algorithm was developed, the Surgical Prioritization and Ranking Tool and Navigation Aid for Head and Neck Cancer (SPARTAN?HN). Agreement was measured during consensus and for algorithm scoring using the Krippendorff alpha. Rankings from the algorithm were compared with expert rankings of 12 case vignettes using the Spearman rank correlation coefficient. Results : A total of 62 indications for surgical priority were rated. Weights for each indication ranged from ?4 to +4 (scale range; ?17 to 20). The response rate for the validation exercise was 100%. The SPARTAN?HN demonstrated excellent agreement and correlation with expert rankings (Krippendorff alpha, .91 [95% CI, 0.88?0.93]; and rho, 0.81 [95% CI, 0.45?0.95]). Conclusions : The SPARTAN?HN surgical prioritization algorithm consistently stratifies patients requiring HNC surgical care in the COVID?19 era. Formal evaluation and implementation are required.
Cancer , résumé, 2019